Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: Implications for pre-therapeutic prediction of treatment outcomes with 99mTc-sestamibi, 201Tl chloride and 99mTc-HL91

European Journal of Nuclear Medicine

Volumn 29, Issue 8, 2002, Pages 1006-1011

  Kinuya, Seigo ^a,b,c,d   Yokoyama, Kunihiko ^a,b,c,d   Li, Xiao Feng ^a,b,c,d   Bai, Jingming ^a,b,c,d   Watanabe, Naoto ^a,b,c,d   Shuke, Noriyuki ^a,b,c,d   Takayama, Teruhiko ^a,b,c,d   Bunko, Hisashi ^a,b,c,d   Michigishi, Takatoshi ^a,b,c,d   Tonami, Norihisa ^a,b,c,d  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

99mTc HL91; 99mTc sestamibi; Hypoxia; Pre therapeutic prediction; Tumour uptake

Indexed keywords

HYDRALAZINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN; OXYGEN; THALLIUM CHLORIDE TL 201; UPENAZIME TC 99M; DIAGNOSTIC AGENT; OXIME; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 4,9 DIAZA 3,3,10,10 TETRAMETHYLDODECAN 2,11 DIONE DIOXIME; TECHNETIUM TC 99M 4,9-DIAZA-3,3,10,10-TETRAMETHYLDODECAN-2,11-DIONE DIOXIME; THALLIUM; THALLIUM CHLORIDE;

AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CELL SUSPENSION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG UPTAKE; FEMALE; GAS FLOW; HUMAN; HUMAN CELL; INCUBATION TIME; MICROELECTRODE; MOUSE; NONHUMAN; OXYGEN TENSION; PREDICTION; SCINTIGRAPHY; TEMPERATURE; TREATMENT OUTCOME; XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BLADDER TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; COLON TUMOR; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; NUDE MOUSE; PHYSIOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; BLADDER CANCER; COLON CANCER; OUTCOME ASSESSMENT; TUMOR XENOGRAFT;

ANIMAL; BLADDER NEOPLASMS; CELL HYPOXIA; COLONIC NEOPLASMS; COMPARATIVE STUDY; FEMALE; HUMAN; HYDRALAZINE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; ORGANOTECHNETIUM COMPOUNDS; OXIMES; OXYGEN; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; THALLIUM; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; ANIMALS; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 0036689904     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0846-x     Document Type: Article

References (35)

1. Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer
2. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein
3. Scintigraphic detection of multidrug resistance in cancer
4. Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrile (sestaMIBI) in evaluation of breast masses: Correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions
5. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma
6. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma
7. 99mTc-MIBI and deoxyglucose in mouse breast cancer models
8. Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: Relation to patient prognosis and chemotherapy response - A preliminary report
9. m-sestamibi uptake in lung cancer: Relationship with clinical response to chemotherapy
10. Technetium-99m-MIBI uptake in small cell lung cancer
11. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer
12. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography
13. Comparative study of Tc-99m MIBI and Tl-201 SPECT in predicting chemotherapeutic response in non-small-cell lung cancer
14. Evaluation of radiotherapeutic response in non-small cell lung cancer patients by technetium-99m MIBI and thallium-201 chloride SPET
15. Functional retention of Tc-99m MIBI in mediastinal lymphomas as a predictor of chemotherapeutic response demonstrated by consecutive thoracic SPECT imaging
16. Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression
17. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects
18. Technetium-99m-labeled HL91 to identify tumor hypoxia: Correlation with fluorine-18-FDG
19. Technetium-99m HL91 uptake as a tumour hypoxia marker: Relationship to tumour blood flow
20. 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo
21. 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia
22. 99mTc]HL-91: Correlation with microelectrode measurements
23. Hydralazine-induced tumor hypoxia: A potential target for cancer chemotherapy
24. 4-methylthiosemicarbazone): Effect of changes in tissue oxygenation
25. Improved response of colon cancer xenografts to radioimmunotherapy with pentoxifylline treatment
26. 201Tl SPET to predict the response to radiotherapy in patients with head and neck cancer
27. Blood flow of human soft tissue sarcomas measured by thallium-201 scanning: Prediction of tumor response to radiation
28. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines
29. 201Tl in a tumour cell line
30. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells
31. Modulators and substrates of p-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells
32. Non-p-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line
33. Hypoxia-induced drug resistance: Comparison to P-glycoprotein-associated drug resistance
34. The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in Chinese hamster lung fibroblasts and human breast-cancer cells in vitro
35. BMS181321 accumulation in rodent and human cells: The role of P-glycoprotein